Amedisys Reports First Quarter 2021 Financial Results Updates 2021 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Qtrex Quantum executives plan to buy up to 2M shares over 12 months
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
Amedisys (AMED) Tops Q1 EPS by 7c
April 28, 2021 4:13 PM EDTAmedisys (NASDAQ: AMED) reported Q1 EPS of $1.50, $0.07 better than the analyst estimate of $1.43. Revenue for the quarter came in at $537.14 million versus the consensus estimate of $544.86 million.
Paul B. Kusserow, Chairman and Chief Executive Officer stated, I am proud of our first quarter results and our continued performance in our four... More
